Stoneridge Investment Partners’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-35
| Closed | -$26K | – | 249 |
|
|
2017
Q4 | $26K | Sell |
35
-2
| -5% | -$1.49K | ﹤0.01% | 219 |
|
|
2017
Q3 | $11K | Hold |
37
| – | – | ﹤0.01% | 238 |
|
|
2017
Q2 | $10K | Sell |
37
-103
| -74% | -$27.8K | ﹤0.01% | 251 |
|
|
2017
Q1 | $46K | Sell |
140
-53
| -27% | -$17.4K | 0.01% | 305 |
|
|
2016
Q4 | $116K | Hold |
193
| – | – | 0.02% | 279 |
|
|
2016
Q3 | $219K | Sell |
193
-1
| -0.5% | -$1.14K | 0.03% | 242 |
|
|
2016
Q2 | $213K | Hold |
194
| – | – | 0.03% | 252 |
|
|
2016
Q1 | $250K | Sell |
194
-82
| -30% | -$106K | 0.04% | 250 |
|
|
2015
Q4 | $678K | Sell |
276
-43
| -13% | -$106K | 0.09% | 182 |
|
|
2015
Q3 | $352K | Sell |
319
-5
| -2% | -$5.52K | 0.05% | 232 |
|
|
2015
Q2 | $326K | Buy |
324
+95
| +41% | +$95.6K | 0.04% | 240 |
|
|
2015
Q1 | $233K | Buy |
229
+135
| +144% | +$137K | 0.03% | 242 |
|
|
2014
Q4 | $312K | Buy |
94
+20
| +27% | +$66.4K | 0.04% | 215 |
|
|
2014
Q3 | $216K | Buy |
+74
| New | +$216K | 0.03% | 220 |
|